H.C. Wainwright Reiterates Buy Rating on atai Life Sciences N.V (ATAI)

March 10, 2026 7:23 AM

H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating and $25.00 price target on atai Life Sciences N.V (NASDAQ: ATAI).The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found